Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries

We are analyzing https://link.springer.com/article/10.1007/s00018-017-2628-4.

Title:
Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy | Cellular and Molecular Life Sciences
Description:
Cryptic MHC I-associated peptides (MAPs) are produced via two mechanisms: translation of protein-coding genes in non-canonical reading frames and translation of allegedly non-coding sequences. In general, cryptic MAPs are coded by relatively short open reading frames whose translation can be regulated at the level of initiation, elongation or termination. In contrast to conventional MAPs, the processing of cryptic MAPs is frequently proteasome independent. The existence of cryptic MAPs derived from allegedly non-coding regions enlarges the scope of CD8 T cell immunosurveillance from a mere ~2% to as much as ~75% of the human genome. Considering that 99% of cancer-specific mutations are located in those allegedly non-coding regions, cryptic MAPs could furthermore represent a particularly rich source of tumor-specific antigens. However, extensive proteogenomic analyses will be required to determine the breath as well as the temporal and spatial plasticity of the cryptic MAP repertoire in normal and neoplastic cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Business & Finance
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

pubmed, article, google, scholar, cas, central, cell, translation, human, class, mhc, van, nat, reading, peptides, cancer, antigen, immunol, nature, biol, med, cells, exp, open, res, mol, cryptic, initiation, rev, gene, perreault, frames, ribosomal, protein, sci, acids, peptide, nucleic, lymphocytes, alternative, codon, complex, usa, response, atkins, readthrough, frameshifting, molecules, proc, natl,

Topics {✒️}

selective graft-versus-leukemia depends month download article/chapter aug-initiated n-terminal extensions paired-end rna-seq data melanoma-reactive tumor-infiltrating lymphocytes microsatellite-instable haematological malignancies van der horst-bruinsma class i-restricted cytotoxic target-specific immune responses ribosome-profiling data reveals melanoma-shared tumor antigen van luxemburg-heijs sa ovalbumin peptide/kb complex pre-spliced rnas cd8+ t-cell responses tapasin-negative cell line treating msi + blood cancers frame peptide/mhc class natural suppressor trnas annotated protein-coding genes full article pdf major histocompatibility complex allele-specific motifs revealed frame aug codon prevalent translational repressors open reading frames stop codon read alternative reading frames aug initiator codon cell-based cancer immunotherapy translational readthrough cap-dependent scanning mechanism programmed ribosomal frameshifting mass-spectrometry-based draft stop codon suppression canonical reading frames article laumont primary initiation codon tyrosinase-related protein van der stok canadian research chair termination complex formation privacy choices/manage cookies tumor-infiltrating cd8 ctl epitopes encoded related subjects ribosome profiling data ivanov ip gerashchenko mv mammalian cells reveals

Questions {❓}

  • Van Deutekom HW, Kesmir C (2015) Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy
         description:Cryptic MHC I-associated peptides (MAPs) are produced via two mechanisms: translation of protein-coding genes in non-canonical reading frames and translation of allegedly non-coding sequences. In general, cryptic MAPs are coded by relatively short open reading frames whose translation can be regulated at the level of initiation, elongation or termination. In contrast to conventional MAPs, the processing of cryptic MAPs is frequently proteasome independent. The existence of cryptic MAPs derived from allegedly non-coding regions enlarges the scope of CD8 T cell immunosurveillance from a mere ~2% to as much as ~75% of the human genome. Considering that 99% of cancer-specific mutations are located in those allegedly non-coding regions, cryptic MAPs could furthermore represent a particularly rich source of tumor-specific antigens. However, extensive proteogenomic analyses will be required to determine the breath as well as the temporal and spatial plasticity of the cryptic MAP repertoire in normal and neoplastic cells.
         datePublished:2017-08-19T00:00:00Z
         dateModified:2017-08-19T00:00:00Z
         pageStart:607
         pageEnd:621
         sameAs:https://doi.org/10.1007/s00018-017-2628-4
         keywords:
            Major histocompatibility complex class I
            Cytotoxic T cells
            Antigen processing
            Antigen presentation
            Protein synthesis
            Neoantigens
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig3_HTML.gif
         isPartOf:
            name:Cellular and Molecular Life Sciences
            issn:
               1420-9071
               1420-682X
            volumeNumber:75
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Céline M. Laumont
               affiliation:
                     name:Université de Montréal
                     address:
                        name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
                        type:PostalAddress
                     type:Organization
                     name:Université de Montréal
                     address:
                        name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Claude Perreault
               url:http://orcid.org/0000-0001-9453-7383
               affiliation:
                     name:Université de Montréal
                     address:
                        name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
                        type:PostalAddress
                     type:Organization
                     name:Université de Montréal
                     address:
                        name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
                        type:PostalAddress
                     type:Organization
                     name:Hôpital Maisonneuve-Rosemont
                     address:
                        name:Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy
      description:Cryptic MHC I-associated peptides (MAPs) are produced via two mechanisms: translation of protein-coding genes in non-canonical reading frames and translation of allegedly non-coding sequences. In general, cryptic MAPs are coded by relatively short open reading frames whose translation can be regulated at the level of initiation, elongation or termination. In contrast to conventional MAPs, the processing of cryptic MAPs is frequently proteasome independent. The existence of cryptic MAPs derived from allegedly non-coding regions enlarges the scope of CD8 T cell immunosurveillance from a mere ~2% to as much as ~75% of the human genome. Considering that 99% of cancer-specific mutations are located in those allegedly non-coding regions, cryptic MAPs could furthermore represent a particularly rich source of tumor-specific antigens. However, extensive proteogenomic analyses will be required to determine the breath as well as the temporal and spatial plasticity of the cryptic MAP repertoire in normal and neoplastic cells.
      datePublished:2017-08-19T00:00:00Z
      dateModified:2017-08-19T00:00:00Z
      pageStart:607
      pageEnd:621
      sameAs:https://doi.org/10.1007/s00018-017-2628-4
      keywords:
         Major histocompatibility complex class I
         Cytotoxic T cells
         Antigen processing
         Antigen presentation
         Protein synthesis
         Neoantigens
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-017-2628-4/MediaObjects/18_2017_2628_Fig3_HTML.gif
      isPartOf:
         name:Cellular and Molecular Life Sciences
         issn:
            1420-9071
            1420-682X
         volumeNumber:75
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Céline M. Laumont
            affiliation:
                  name:Université de Montréal
                  address:
                     name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
                     type:PostalAddress
                  type:Organization
                  name:Université de Montréal
                  address:
                     name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Claude Perreault
            url:http://orcid.org/0000-0001-9453-7383
            affiliation:
                  name:Université de Montréal
                  address:
                     name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
                     type:PostalAddress
                  type:Organization
                  name:Université de Montréal
                  address:
                     name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
                     type:PostalAddress
                  type:Organization
                  name:Hôpital Maisonneuve-Rosemont
                  address:
                     name:Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences
      issn:
         1420-9071
         1420-682X
      volumeNumber:75
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Université de Montréal
      address:
         name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
         type:PostalAddress
      name:Université de Montréal
      address:
         name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
         type:PostalAddress
      name:Université de Montréal
      address:
         name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
         type:PostalAddress
      name:Université de Montréal
      address:
         name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
         type:PostalAddress
      name:Hôpital Maisonneuve-Rosemont
      address:
         name:Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Céline M. Laumont
      affiliation:
            name:Université de Montréal
            address:
               name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
               type:PostalAddress
            type:Organization
            name:Université de Montréal
            address:
               name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
               type:PostalAddress
            type:Organization
      name:Claude Perreault
      url:http://orcid.org/0000-0001-9453-7383
      affiliation:
            name:Université de Montréal
            address:
               name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
               type:PostalAddress
            type:Organization
            name:Université de Montréal
            address:
               name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
               type:PostalAddress
            type:Organization
            name:Hôpital Maisonneuve-Rosemont
            address:
               name:Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
      name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
      name:Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Canada
      name:Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Canada
      name:Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(562)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

6.03s.